Screening and monitoring serum bilirubin (SBR) in neonates is Background: crucial to prevent neonatal hyperbilirubinemia (NH)-associated morbidity and mortality worldwide. A lack of resources is often a barrier for measuring SBR in developing countries. Reliable, cost-effective, easy to use point-of-care (POC) SBR tests are needed. This study aimed to evaluate the technical accuracy and usability of the Bilistick System (BS), a new bilirubin POC test, in a tropical setting.
Introduction
Neonatal hyperbilirubinemia (NH), a common disorder worldwide, has a benign course if promptly managed. However, in settings with limited access to diagnosis and care, there is a higher morbidity and mortality risk 1 . Accurate testing for elevated serum bilirubin (SBR) in the first days of life, followed by appropriate treatment with phototherapy, is crucial to prevent brain damage in infants 2, 3 . Serum bilirubin concentration is the gold standard reference for determining NH management 2-5 , and it is done by laboratory-based colorimetric assay, which requires large blood volumes and a fully-equipped laboratoryoften beyond the reach of clinics in low-resource settings. While visual assessment by Kramer zone scores 6 poorly correlates with bilirubin concentration 7-9 , transcutaneous bilirubinometers (TcB) have proven to be an alternative to invasive blood sampling [10] [11] [12] . However, TcB may underestimate high SBR and, as they assess extravascular bilirubin, are unreliable if the neonate has received phototherapy treatment [13] [14] [15] . The need for postnatal age-and ethnicity-specific nomograms further complicate TcB use 16, 17 .
Frontline health workers in low-resource settings need reliable and cost-effective point-of-care (POC) tests for early screening of neonates at risk, timely treatment or referral when phototherapy is not locally available and monitoring of neonates requiring treatment. A promising, low-cost device called BiliSpec has been field tested in Malawi, showing good agreement with the standard reference (Pearson's correlation, r=0.97) and a mean difference of 5.1 µmol/l with 95% confidence interval between −29.1 and 37.6 µmol/l
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. An alternative POC device is the Bilistick (BS) system, which features a hand-held, batteryoperated machine requiring a smaller blood volume and generating a faster result than the standard laboratory test. When compared with laboratory assays on duplicate plasma samples of 118 neonates in Italy and Egypt under ideal conditions, BS showed an acceptable mean underestimation of SBR levels of 10.3 µmol/l and a 95% confidence interval between −38.0 and 58.7 µmol/l 19 . In 2017, in a tertiary care referral centre in Cairo, samples from neonates with SBR less than 340 µmol/l were used to investigate the accuracy of the BS on venous blood 20 . The study concluded that BS had comparable accuracy to the TcB JM-103. A recent multi-centre study reported the BS to slightly underestimate SBR value with maximum limits of agreements of −128.3 to 102.6 µmol/l 21 .
These findings suggest that new POC assays to diagnose NH have promise for use in low-resource settings, but there is insufficient evidence to make strong recommendations. The current study used a mixed-methods approach to evaluate two important features of the BS: (i) the technical accuracy of the BS in tropical field conditions, and (ii) usability of the device among locally trained staff in a low resource setting.
Methods

Outline and location
This prospective, mixed-methods study was conducted by the Shoklo Malaria Research Unit (SMRU) at the Wang Pha clinic, located along the Thailand-Myanmar border in the north-western province of Tak, Thailand. The study evaluated BS during two distinct periods: from the end of January until the end of April 2017, and from the beginning of June until the end of December 2017.
The field clinic and on-site laboratories have stable electricity, basic equipment and refrigerators. The staff consists of locally trained medics, midwives, nurses, health workers and laboratory technicians. Prior to starting the study, all midwives (n=13) and 3 laboratory technicians were asked and agreed to participate to the study. They were then trained on use of the BS system. The training module was created and conducted by the first author (L.T.) based on protocols developed by the manufacturer; user instructions were simplified and translated for the local staff. The training consisted of two sessions: 1 hour of theory with a step-by-step description of the procedure supported by pictures and videos, followed by 1 hour of practical, hands-on training.
The study included neonates born at ≥35 weeks of gestational age, in stable clinical condition, and requiring bilirubin measurement for either (i) a grade 3 or higher jaundice observed visually as per the Kramer scale 6, 8 , or (ii) a previous, borderline SBR measurement (i.e. ≤ 50 µmol/l below the treatment threshold of the British National Institute for Health and Care Excellence (NICE) guidelines 3 ). All parents of neonates who met the inclusion criteria were proposed to participate in the study. The study was explained in the preferred local language and the parents who agreed in participating signed an informed consent form.
Since the BS required a haematocrit (HCT) ≤65% to provide a reading, neonates with a prior HCT >65% or no prior HCT measured were not eligible. Each infant enrolled contributed to one measurement only.
Gestational age was defined by ultrasound 22, 23 . Neonatal age in hours and phototherapy treatment at time of SBR measurement were reported systematically.
Technical validation
Simultaneously, two blood samples were collected by heel prick: one (50 µl) in a heparinized capillary tube for laboratory testing and one (25 µl) in a non-heparinized transfer pipette for BS.
The first 50-µl blood sample was used for the routine laboratory bilirubinometer SBR testing and transferred to the on-site clinic laboratory within 10 minutes of collection. The laboratory staff centrifuged the capillary tube (3 min at 10,000 rotations per minute) to separate red blood cells from plasma and estimate HCT using a Hawksley micro-haematocrit reader. To ensure quality, the accuracy of capillary HCT reading was assessed independently from this study. A total of 90 consecutive HCTs were independently read by two laboratory staff. The maximum observed difference was 11 HCT points; in 54% (48/89) of the samples, the two reading were the same, in 37% (33/89) the difference was 1 HCT point and in 9% (8/89) a difference of ≥2 HCT points was observed. There were no statistical differences between paired HCT (Wilcoxon matched pairs signed rank test, p=0.089).
In the study, after HCT reading, the same tube was used to measure SBR using the dual-wavelength BR-501 bilirubinometer (Apel Co., Ldt, Japan) according to manufacturer's instructions. The BR-501 bilirubinometer has ± 5% accuracy within the measurement range (0-30 mg/dl), as reported by the manufacturer.
The second blood sample was used for the study device. The BS system (Bilimetrix srl, Italy) consists of a hand-held reflectance reader that uses test strips composed of a filter coupled with a nitrocellulose membrane (Supplementary File 1 and http:// www.bilimetrix.net/). The device is powered by rechargeable batteries. The BS calibration was checked weekly according to the manufacturer's instructions and kept under ambient conditions for the entire duration of the study. The test strips were kept in their humidity-proof packaging and were exposed to ambient conditions for a few seconds prior to performing the test.
The test was performed according to the manufacturer's instructions after computerized installation and registration. Although the reader was designed for a single operator, the midwives decided to perform the test in pairs. One midwife inserted a test strip in the BS system for calibration (38 sec to determine the reflectance of the dry strips) while the second midwife collected the two blood samples via heel prick. The blood was loaded on the strip within 2 minutes of instrument calibration. Measurement was displayed within 100 seconds (Supplementary File 1) . If the blood was not loaded within 2 minutes of the calibration, the strip had to be removed and the reader required 2 additional minutes to reset prior to accepting a new strip. The new strip would require a new calibration and the total time would potentially cause clotting of the blood. After each test, a visual evaluation of the strip was performed by the operator to confirm saturation of the membrane. If the reader was unable to indicate an accurate result for the bilirubin level, it generated an error message displayed on the BS screen. As per approved protocol, neonates were not pricked a second time and the BS test was not repeated when clotting occurred or error outputs messages were displayed.
Temperature and room humidity were recorded with a temperature hygrometer at the time of the test. Humidity level was classified as either normal or high humidity (< 75% or ≥ 75%, respectively).
Usability assessment
The mixed-methods approach employed both exploratory and explanatory design and was used to evaluate the usability of the BS system. This included observation by laboratory technicians of technical procedures performed by the midwives and midwives' assessment of the device's ease of use through focus group discussions (FGD) and a self-administered questionnaire. The questionnaire and FGD took place after 6 months of using the BS. This mixed-methods approach also allowed for triangulation through independent qualitative analysis of FGD data by two investigators (L.T., A.H.), and mutual corroboration between observed technical errors and midwives' evaluation of the device's ease of use via questionnaire.
A total of three laboratory technicians evaluated each step of the process using an internal assessment checklist (Supplementary File 2) and reported technical issues (e.g., blood clotting).
After providing written informed consent, midwives filled in a 5-point Likert scale, self-administered questionnaire that was developed based on the operating procedures of the user manual (Supplementary File 3). The questions were translated into the local language (Sgaw Karen), back-translated, and finalized prior to conducting this component of the study. The 5-point Likert scale ranged from "Strongly disagree" (score 1) through "Neutral" (score 3) to "Strongly agree" (score 5).
After completing the questionnaire, midwives participated in FGD to explore their experiences working with the BS device (Supplementary File 4) . FGD guides and questions were developed based on investigator knowledge and information shared by the manufacturer. FGD guides were translated into Sgaw Karen, back-translated and finalized prior to conducting FGD. To promote an environment in which participants felt comfortable talking, participants were purposively selected to form groups similar in clinical experience. There were two focus groups conducted, one with six junior and senior midwives and one with seven assistant midwives. The FGD facilitator (M.K.P.) was fluent in Sgaw Karen, the preferred language of the midwives, and assisted by L.T. FGD were audio-recorded and transcribed directly to English by a translator unfamiliar and uninvolved in the study.
Data analysis
Sample size calculations for technical validity of BS assumed a power of 80%, an effect size of 0.25 and α = 0.0125, yielding a sample size of at least 180 samples needed to detect a statistically significant difference in measurement compared to routine laboratory bilirubinometer via two-tailed paired t-test. Proportions were compared using chi-square test and Mann-Whitney U-test was used for comparison of medians. A Bland-Altman plot was used to graphically inspect differences between the two tests. In order to create an easy-to-use scale to analyse, two questions of the self-administered questionnaire (nr1 and nr9) had to be reversed. Scores were then described using median (IQR) and their distribution demonstrated by a histogram. Reliability of the questionnaire was assessed by the Cronbach alpha coefficient 24, 25 .
Ethical clearance
The study was approved by the Ethic Committees of the University of Oxford, UK (OXTREC 5115-16) and the Faculty of Tropical Medicine, Mahidol University, Thailand (TMEC16-073). The Tak Community Advisory Board, consisting of members of the local community, also revised and approved the study (TCAB-05/Rev/2016). All 13 midwives trained to perform the BS consented to the self-administered questionnaire and participate in FGD. Written informed consent was obtained from the parents or guardian of the neonates.
Results
Overview of validation data
Consent was obtained from parents of 180 eligible neonates. In total, three tests were excluded from analysis because the laboratory technicians were unavailable to supervise the procedure; four additional tests were excluded from further evaluation: three had insufficient amounts of blood to complete the BS test, and the reader stopped functioning during one test, yielding an incomplete test result. Overall, BS was performed on 173 blood samples (Figure 1 ).
Most neonates enrolled in the study were born at term (162/173, 93.6%). The test was done at a median age of 4 days; the median (IQR) value of the last HCT prior to recruitment was 57 (54-61), ranging from 31% to 65% and the median (IQR) HCT value at recruitment was 55% (52-60). Eleven samples had a HCT value above 65%, the cut-off HCT to allow correct saturation of the BS strip membrane. Median room temperature at time of sampling was 28.9°C (range: 23-36°C) and humidity 67% (range: 39-89%). A total of eight neonates were under phototherapy treatment at the time of sampling (Table 1) .
Technical validation
There were two readers used over the course of this study (Supplementary File 5). An error message was generated by the reader for the all the 11 samples above the HCT threshold of readability (>65%) and no SBR readout was available (Table 2 ). Furthermore there was no SBR readout in 75% (54/72) samples with a HCT range of 56-65% and in 22% (19/87) samples with a HCT range of 41-55% (Table 2 ).
There were three types of reader-generated error messages encountered (Supplementary File 6); EC:T06 (Uncomplete reading procedure within the established time), EC:B03 (Error identified during the initial phase of the bilirubin measurement) and EC:B04 (Error identified during the bilirubin measurement). The majority (64/84, 76.2%) were due to a failure of the reading procedure (described by the manufacturer as potentially linked to the HCT level). They were all found in equal proportion at different humidity levels (<75%, ≥75%, p=0.242), but the proportion of error "EC:B04" (i.e., insufficient test strip saturation) was significantly lower (p=0.004) with Reader #2 (Supplementary File 6) . The proportion of reader-generated error messages did not differ significantly among different midwives (p=0.306) or over time (chi-square for trend per month, p=0.392) and was not associated with gestational age, room temperature or humidity (Table 1) . Supplementary File 5 reports the history of reader-generated error messages and the technical support needed from manufacturers during the course of the study.
Of the 89 samples with an available SBR result, 7 were excluded from further analysis: the reader reported haemolysis for 6 tests and one had no laboratory bilirubin measured (Figure 1 ). The remaining 82 BS measurements could be compared with routine laboratory bilirubinometer SBR results: 36 from Reader #1 and 46 from Reader #2.
Reader #2 was mostly used during a period of high humidity (58.7% of the tests) and on samples with higher HCT (Table 3) . The correlation between BS and routine laboratory bilirubinometer SBR was higher for Reader #1; the Pearson's correlation coefficient (r) was 0.97 (95% CI: 0.93-0.98) compared to 0.71 (95% CI: 0.53-0.83) for Reader #2 (Figure 2A, B) . Taking the two readers together, this correlation varied depending on the ambient humidity; there was a high correlation at humidity levels < 75% with a Pearson's correlation coefficient r =0.96 (95% CI: 0.94 to 0.98), but it decreased to 0.62 (95% CI: 0.34 to 0.80) when measurements were done at high levels of humidity (≥ 75%). The HCT also influenced the BS measurement accuracy with a correlation coefficient of 0.95 (95% CI: 0.91 to 0.97) for the HCT range of 31-55% and 0.48 (95% CI: −0.04 to 0.80) for the HCT of 56−65%.
When the humidity and HCT conditions were combined, the highest correlation was found for the HCT range 30-56% at humidity levels of < 75% (r=0.97 (95% CI: 0.88-1.00)) and the lowest correlation was at a HCT range of 56-65% at levels of high humidity (r=0.29 (95% CI: 0.03-0.65)) ( Table 4 ).
The Bland-Altman plot of the BS measurements (µmol/l) against routine laboratory bilirubinometer SBR performed at an ambient humidity of <75% (n=52) showed an acceptable mean difference of −20 µmol/l (limits of agreement −59 to 18). The maximum observed difference was −74 µmol/l ( Figure 3A) . At ambient humidity levels ≥75% (n=30) there was a mean difference of −21 µmol/l with wide limit of agreement of −117 to 75 and a high maximum difference of −211 µmol/l ( Figure 3B ).
Usability assessment
Direct observation of 173 sample measurements. Midwives were consistently able to insert the strip into the reader, draw blood with the pipette, load blood onto the strips and read the results. The laboratory technicians reported a total of 9 major (5.2%) and 3 minor (1.7%) inaccuracies while observing midwives performing the procedure (Supplementary File 2) . The most frequent error was the formation of blood bubbles while loading the strip (n=9). All 12 observed errors happened within the first 3 months of the study (first month n=5, second month n=2, third month n=2); 10 of those errors led to a reader-generated error message (Supplementary File 2) , while the remaining two gave valid results (no haemolysis was reported by the reader).
Blood clotting was reported in two instances when the blood was not loaded within 2 minutes of the strip calibration, leading to the need of performing a new calibration and thus a delay in reading. Both tests led to a reading error message (Supplementary File 6).
Focus group discussion. Emergent themes included: knowledge acquisition, midwife experience around training and use of BS; the clinical potential and considerations in implementing the BS at a larger scale; and midwife report of parents' experiences.
Midwives knew the importance of screening for and diagnosing NH. The overall impression of midwives was that the training was simple, easy to understand, and greatly enhanced by the use of pictures. In fact, midwives thought that easy mastery of the instrument indicated that BS was appropriate to use in more Parental concern arose as an important theme in discussions with midwives. Midwives reported that parents expressed concern and fear of heel pricks that may cause the infant pain. Thus, midwives would worry about having to repeat the tests due to BS error and often had to spend time counselling parents on the importance of heel pricks or repeat heel pricks for accurate diagnosis of NH. One assistant midwife mentioned that the parents of a baby, having witnessed multiple heel pricks, became increasingly wary of causing the infant undue pain leading them to avoid even routine immunizations.
'[The parents] have compassion on the children when they seethattheprickhurttheirchildren.Butparentsdon'taccept if [midwives] repeat the prick too many times. There's a timethattheytellus...Ithappensthatthey[parents]rejected vaccination because their children had been pricked so manytimes'-Assistantmidwife
Usability questionnaire. All thirteen midwives completed the questionnaire. Supplementary File 7 shows the distribution of participant's answers on a 5-point Likert scale. The midwives agreed on the ease of use, with a median (IQR) score of 4 (4-4). The two questions that rated low were the only two negative statements; one about the training, "I did not need to learn a lot of things before I could get going with the Bilistick system" and one on the ability of the midwife to perform the test independently, "I don't need the support of a technical person (lab technician) to be able to use properly the Bilistick system". The results on these two statements were not in line with the midwives' experiences assessed by FGD and it was suspected that the construction of the question as a negative was misunderstood. Cronbach alpha coefficient for Likert scale questions inter-reliability was low (0.5) with all statements included, but increased to acceptable internal reliability levels of 0.8 after removing the two negative statements. The median score remained the same after the two negative statements were removed.
Discussion
This study evaluated the hand-held bilirubin reader BS system developed to measure and display SBR concentration, for technical accuracy and usability in a low-resource setting 20 .
The studied population was healthy near-term and term neonates in their first days of life (median age 4 days) with a high median capillary HCT of 55%. The young postnatal age and the use of capillary blood in the current study may explain the high HCT levels observed 26, 27 . Moreover, delayed cord clamping is regularly practiced at the SMRU clinic according to WHO recommendations 28 resulting in newborns having a median HCT of 59% (IQR, 54-64) at 24 hours of life 29 , a value similar to other settings worldwide 26, 27, 30 . This population contrasts with that of the three previous studies that tested the BS under ideal conditions: in the first study, neonates had a lower mean HCT value of 41.5%
19
, those enrolled in the second study were of an older median age of 6 days with venous blood 20 and in the most recent multi-centre study, the median HCT was 42.7% IQR (38.0-48.0) at a median age of 4 days 21 .
The current study detected a clear limitation of the readers in analysing SBR levels starting from HCT range 41-55% and major limitation in the HCT range 55-65%. Greco et al. documented a proportion of 6.8% (11/161) of technical problems using venous blood in older neonates 20 , while the current study experienced 48.6% of "reader-generated error messages". Overall, the device in its current formulation would not be suitable for screening in the early hours of life when mean HCT often ranges from 55 to 60% 26, 27, 30 and in settings where capillary sampling is used.
For the tests that yielded a result, the accuracy of both BS readers with humidity <75% were similar to those already published, showing comparable measures of the BS system by non-invasive rapid transcutaneous bilirubinometers 20 . However, the BS accuracy was reduced with increasing HCT value (>55%) and higher humidity (≥75%). Had the BS test been used for NH diagnosis and management, only one neonate would have met the criteria for phototherapy according to NICE guidelines, compared to the five neonates diagnosed by routine laboratory bilirubinometer SBR. Given its lack of utility in younger neonates and its inaccuracy at high humidity and HCT levels, this study concludes that BS in its current configuration is not reliable for early screening of NH in this tropical setting.
This technical evaluation had some limitations: the BS was not compared to the gold standard, which would have required a larger volume of blood with venous sampling and analysis at the central laboratory in Mae Sot (30 km away). Moreover, due to the limited number of strips available, the high rates of errors, and the use of two different BS readers, the number of samples analysed in similar environmental conditions was small. At the time of manuscript submission, the BS manufacturer has already changed some features of the test strips and reports proper performances with blood sample with HTC up to 70%; further investigation will be required to assess the performances of the new device.
Assessing usability through both exploratory (observation) and explanatory (FGD, questionnaire) methods proved a strong approach. It confirmed that not only was the absence of SBR readout frequent, but that it gave the user considerable anxiety. Importantly, direct observation by laboratory technicians highlighted the small number of errors performed by the midwives when performing the BS test. Therefore, the assertion by the midwives that the device was easy to use, required limited training, and could be mastered in more remote settings is valid. However, the data from the usability assessment support the technical validation: the system proved to be poorly suited for low resource settings 31 . More specific caveats in the use of this system require particular attention. The device required a level of technological capacity often beyond the means of low-resource settings 31 . For example, the device requires computerized installation, registration prior to use, and-if technical assistance is required-remote internet access with compatible software. In addition to these technological constraints, one must consider the local capacity in information technology support to troubleshoot as problems arise. Secondly, the test itself required metered blood collection with a specific pipette, prompt loading of the strip as the pipettes are non-heparinized, and recalibration between each sample. Very strict time constraints are impractical in settings where the operator needs to sample blood from a newborn in a busy clinic. Although midwives reported the test to be easy to use, they spontaneously started performing the test in pairs in spite of its single-operator design. In addition to these clinical concerns, perceived infant discomfort of heel pricks led some parents to be sceptical of SBR testing; repeated sampling in a short time, because of close monitoring for borderline SBR values, in apparently healthy babies can be perceived as very distressing to the parents. This indicates the need to find a less invasive bilirubin screening tool for this setting.
Improving the performance under high humidity and with higher HCT levels, possibly with an improved strip matrix, could potentially make the BS system suitable for tropical settings. Heparinized pipettes, longer times for loading the sample on the strip or alternatively, collecting blood from a heel prick directly onto the strip, may improve the usability of the system. Minor changes such as results being displayed for a longer period of time and options to select preferred measurement units would benefit the system.
In conclusion, despite its innovative approach and easiness to use, the BS tested at SMRU is not suitable for SBR measurement in tropical, low-resource settings.
Data availability
Due to ethical and security considerations, the data that supports the findings in this study can be accessed only through the Data Access Committee at Mahidol Oxford Tropical Medicine Research Unit (MORU). The data sharing policy can be found here: http://www.tropmedres.ac/data-sharing. The application form for datasets under the custodianship of MORU Tropical Network can be found in Supplementary File 8. Robert D Christensen Division of Neonatology, University of Utah, Salt Lake City, UT, USA Thielemans report a prospective investigation of the feasibility and diagnostic accuracy of a potential et al. method for quantifying serum bilirubin in a tropical, low-resource, setting. The device is called the Bilistick System, and involves a small quantity of blood, typically drawn by heel-stick, and run as in a battery-operated, point of care system. These features would render this method far more practical and economical than standard laboratory-based serum bilirubin testing.
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Severe hyperbilirubinemia that goes undetected and untreated can lead to acute bilirubin encephalopathy, when bilirubin crosses from blood to brain and damages, sometimes permanently, the central nervous system. The consequent death or life-long handicapping conditions, often consisting of deafness and athetoid cerebral palsy, place a large burden on families and societies. This tragic condition is one of the most heart-wrenching medical safety concerns in global pediatrics, because the damage is, in theory, completely preventable with early recognition and treatment of neonatal hyperbilirubinemia.
The device did not test sufficiently well as to recommend its use in present configuration. However, the study appears to have been well conceived and executed and may give others the focus needed to improve the performance of this system, particularly in conditions with hematocrits above 55% and humidity condition above about 75%.
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